The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial

Veronica Ojetti; Giovanni Gigante; Maurizio Gabrielli; Me Ainora; Alice Mannocci; Ec Lauritano; Giovanni Battista Gasbarrini; Antonio Gasbarrini

The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial

Veronica Ojetti, Giovanni Gigante, Maurizio Gabrielli, Me Ainora, Alice Mannocci, Ec Lauritano, Giovanni Battista Gasbarrini, Antonio Gasbarrini

Research output: Contribution to journal › Article

44 Citations (Scopus)

Abstract

Lactase enzyme supplements and probiotics with high beta-galactosidase activity may be valid treatment options for the lactose intolerance. Aim of this study was to assess whether supplementation with tilactase or Lactobacillus reuteri when compared to placebo affects hydrogen breath excretion and gastrointestinal symptoms in lactose intolerant patients during lactose breath test (H,-LBT).

Original language	English
Pages (from-to)	163-170
Number of pages	8
Journal	European Review for Medical and Pharmacological Sciences
Volume	14
Publication status	Published - 2010

Keywords

Abdominal Pain
Administration, Oral
Adult
Breath Tests
Diarrhea
Female
Flatulence
Hormone Replacement Therapy
Humans
Lactase
Lactobacillus reuteri
Lactose
Lactose Intolerance
Male
Pain Measurement
Probiotics
Prospective Studies
Time Factors
Treatment Outcome
beta-Galactosidase

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{eeab5bb4c042420793ff74488595e09b,

title = "The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial",

abstract = "Lactase enzyme supplements and probiotics with high beta-galactosidase activity may be valid treatment options for the lactose intolerance. Aim of this study was to assess whether supplementation with tilactase or Lactobacillus reuteri when compared to placebo affects hydrogen breath excretion and gastrointestinal symptoms in lactose intolerant patients during lactose breath test (H,-LBT).",

keywords = "Abdominal Pain, Administration, Oral, Adult, Breath Tests, Diarrhea, Female, Flatulence, Hormone Replacement Therapy, Humans, Lactase, Lactobacillus reuteri, Lactose, Lactose Intolerance, Male, Pain Measurement, Probiotics, Prospective Studies, Time Factors, Treatment Outcome, beta-Galactosidase, Abdominal Pain, Administration, Oral, Adult, Breath Tests, Diarrhea, Female, Flatulence, Hormone Replacement Therapy, Humans, Lactase, Lactobacillus reuteri, Lactose, Lactose Intolerance, Male, Pain Measurement, Probiotics, Prospective Studies, Time Factors, Treatment Outcome, beta-Galactosidase",

author = "Veronica Ojetti and Giovanni Gigante and Maurizio Gabrielli and Me Ainora and Alice Mannocci and Ec Lauritano and Gasbarrini, {Giovanni Battista} and Antonio Gasbarrini",

year = "2010",

language = "English",

volume = "14",

pages = "163--170",

journal = "European Review for Medical and Pharmacological Sciences",

issn = "1128-3602",

publisher = "Verduci Editore s.r.l",

}

TY - JOUR

T1 - The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial

AU - Ojetti, Veronica

AU - Gigante, Giovanni

AU - Gabrielli, Maurizio

AU - Ainora, Me

AU - Mannocci, Alice

AU - Lauritano, Ec

AU - Gasbarrini, Giovanni Battista

AU - Gasbarrini, Antonio

PY - 2010

Y1 - 2010

N2 - Lactase enzyme supplements and probiotics with high beta-galactosidase activity may be valid treatment options for the lactose intolerance. Aim of this study was to assess whether supplementation with tilactase or Lactobacillus reuteri when compared to placebo affects hydrogen breath excretion and gastrointestinal symptoms in lactose intolerant patients during lactose breath test (H,-LBT).

AB - Lactase enzyme supplements and probiotics with high beta-galactosidase activity may be valid treatment options for the lactose intolerance. Aim of this study was to assess whether supplementation with tilactase or Lactobacillus reuteri when compared to placebo affects hydrogen breath excretion and gastrointestinal symptoms in lactose intolerant patients during lactose breath test (H,-LBT).

KW - Abdominal Pain

KW - Administration, Oral

KW - Adult

KW - Breath Tests

KW - Diarrhea

KW - Female

KW - Flatulence

KW - Hormone Replacement Therapy

KW - Humans

KW - Lactase

KW - Lactobacillus reuteri

KW - Lactose

KW - Lactose Intolerance

KW - Male

KW - Pain Measurement

KW - Probiotics

KW - Prospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - beta-Galactosidase

KW - Abdominal Pain

KW - Administration, Oral

KW - Adult

KW - Breath Tests

KW - Diarrhea

KW - Female

KW - Flatulence

KW - Hormone Replacement Therapy

KW - Humans

KW - Lactase

KW - Lactobacillus reuteri

KW - Lactose

KW - Lactose Intolerance

KW - Male

KW - Pain Measurement

KW - Probiotics

KW - Prospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - beta-Galactosidase

UR - http://hdl.handle.net/10807/21520

M3 - Article

SN - 1128-3602

VL - 14

SP - 163

EP - 170

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

ER -

The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this